BSE Live
Jan 09, 13:19Prev. Close
730.20
Open Price
732.95
Bid Price (Qty.)
745.45 (60)
Offer Price (Qty.)
747.35 (33)
NSE Live
Jan 09, 13:19Prev. Close
730.35
Open Price
736.20
Bid Price (Qty.)
746.35 (2)
Offer Price (Qty.)
747.00 (359)
| Cash Flow of Aarti Pharmalabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 360.69 | 300.49 | 260.77 | 155.38 | |
| Net CashFlow From Operating Activities | 331.56 | 216.35 | 263.00 | -43.70 | |
| Net Cash Used In Investing Activities | -413.90 | -214.56 | -157.80 | -138.74 | |
| Net Cash Used From Financing Activities | 65.44 | 9.72 | -163.47 | 260.38 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -16.90 | 11.51 | -58.28 | 77.94 | |
| Cash And Cash Equivalents Begin of Year | 23.63 | 12.12 | 83.28 | 5.33 | |
| Cash And Cash Equivalents End Of Year | 6.73 | 23.63 | 25.00 | 83.27 |
14.11.2025
AARTIPHARM Consolidated September 2025 Net Sales at Rs 418.33 crore, down 8.67% Y-o-Y
12.11.2025
AARTIPHARM Standalone September 2025 Net Sales at Rs 417.29 crore, up 10.6% Y-o-Y
22.09.2025
19.09.2025
14.11.2025
AARTIPHARM Consolidated September 2025 Net Sales at Rs 418.33 crore, down 8.67% Y-o-Y
12.11.2025
AARTIPHARM Standalone September 2025 Net Sales at Rs 417.29 crore, up 10.6% Y-o-Y
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y